RankingsPricing
  1. US-listed companies
  2. Aldeyra Therapeutics, Inc.
  3. Financials
  4. Return on equity (%)

Aldeyra Therapeutics, Inc.ALDX

Market cap
$297.08M
P/E ratio
SummaryFinancials
Period EndReturn on equity (%) (Million USD)YoY (%)
Dec 31, 2024-58.5+111.34%
Dec 31, 2023-27.7-20.31%
Dec 31, 2022-34.8-20.20%
Dec 31, 2021-43.6-37.60%
Dec 31, 2020-69.8-22.70%
Dec 31, 2019-90.3+46.54%
Dec 31, 2018-61.6-15.52%
Dec 31, 2017-72.9-9.24%
Dec 31, 2016-80.4+3.58%
Dec 31, 2015-77.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)